Altered Cellular and Tissue Biology

Chapter 2

Altered Cellular and Tissue Biology

Kathryn L. McCance, Todd Cameron Grey and George Rodway

Injury to cells and their surrounding environment, called the extracellular matrix, leads to tissue and organ injury. Although the normal cell is restricted by a narrow range of structure and function, it can adapt to physiologic demands or stress to maintain a steady state called homeostasis. Adaptation is a reversible, structural, or functional response to both normal or physiologic conditions and adverse or pathologic conditions. For example, the uterus adapts to pregnancy—a normal physiologic state—by enlarging. Enlargement occurs because of an increase in the size and number of uterine cells. In an adverse condition, such as high blood pressure, myocardial cells are stimulated to enlarge by the increased work of pumping. Like most of the body’s adaptive mechanisms, however, cellular adaptations to adverse conditions are usually only temporarily successful. Severe or long-term stressors overwhelm adaptive processes and cellular injury or death ensues. Altered cellular and tissue biology can result from adaptation, injury, neoplasia, accumulations, aging, or death. (Neoplasia is discussed in Chapters 12, 13, and 14.)

Knowledge of the structural and functional reactions of cells and tissues to injurious agents, including genetic defects, is key to understanding disease processes. Cellular injury can be caused by any factor that disrupts cellular structures or deprives the cell of oxygen and nutrients required for survival. Injury may be reversible (sublethal) or irreversible (lethal) and is classified broadly as chemical, hypoxic (lack of sufficient oxygen), free radical, unintentional or intentional, and immunologic or inflammatory. Cellular injuries from various causes have different clinical and pathophysiologic manifestations. Stresses from metabolic derangements may be associated with intracellular accumulations and include carbohydrates, proteins, and lipids. Sites of cellular death can cause accumulations of calcium resulting in pathologic calcification.

Cellular death is confirmed by structural changes seen when cells are stained and examined with a microscope. The most important changes are nuclear; clearly, without a healthy nucleus, the cell cannot survive.

Cellular aging causes structural and functional changes that eventually lead to cellular death or a decreased capacity to recover from injury. Mechanisms explaining how and why cells age are not known and distinguishing between pathologic changes and physiologic changes that occur with aging is often difficult. Aging clearly causes alterations in cellular structure and function, yet senescence—growing old—is both inevitable and normal.

Cellular Adaptation

Cells adapt to their environment to escape and protect themselves from injury. An adapted cell is neither normal nor injured—its condition lies somewhere between these two states. Cellular adaptations, however, are a common and central part of many disease states. In the early stages of a successful adaptive response, cells may have enhanced function; thus it is hard to differentiate a pathologic response from an extreme adaptation to an excessive functional demand. The most significant adaptive changes in cells include atrophy (decrease in cell size), hypertrophy (increase in cell size), hyperplasia (increase in cell number), and metaplasia (reversible replacement of one mature cell type by another less mature cell type). Dysplasia (deranged cellular growth) is not considered a true cellular adaptation but rather an atypical hyperplasia. These changes are shown in Figure 2-1.


Atrophy is a decrease or shrinkage in cellular size. If atrophy occurs in a sufficient number of an organ’s cells, the entire organ shrinks or becomes atrophic. Atrophy can affect any organ, but it is most common in skeletal muscle, the heart, secondary sex organs, and the brain (Figure 2-2). Atrophy can be classified as physiologic or pathologic. Physiologic atrophy occurs with early development. For example, the thymus gland undergoes physiologic atrophy during childhood. Pathologic atrophy occurs as a result of decreases in workload, use, pressure, blood supply, nutrition, hormonal stimulation, and nervous stimulation. Individuals immobilized in bed for a prolonged time exhibit a type of skeletal muscle atrophy called disuse atrophy. Aging causes brain cells to become atrophic and endocrine-dependent organs, such as the gonads, to shrink as hormonal stimulation decreases. Whether atrophy is caused by normal physiologic conditions or by pathologic conditions, atrophic cells exhibit the same basic changes.

The atrophic muscle cell contains less endoplasmic reticulum and fewer mitochondria and myofilaments (part of the muscle fiber that controls contraction) than does the normal cell. In muscular atrophy caused by nerve loss, oxygen consumption and amino acid uptake are rapidly reduced. The mechanisms probably include decreased protein synthesis, increased protein catabolism, or both. Up-regulation of proteasome (protein degrading complex) activity is characteristic of atrophic muscle changes.1 The primary pathway of protein catabolism is the ubiquitin-proteasome pathway. Proteins degraded in this pathway are first conjugated to ubiquitin (another small protein) and then degraded by proteasomes.

Atrophy as a result of chronic malnutrition is often accompanied by a “self-eating” process called autophagy inducing autophagic vacuoles. These vacuoles are membrane-bound vesicles within the cell that contain cellular debris—small fragments of mitochondria and endoplasmic reticulum—and hydrolytic enzymes. Atrophic change causes a rapid increase in hydrolytic enzymes, which are isolated in autophagic vacuoles to prevent uncontrolled cellular destruction. Thus the vacuoles proliferate as needed to protect the uninjured organelles from the injured organelles and are eventually taken up and destroyed by lysosomes (see p. 7). Certain contents of the autophagic vacuole may resist destruction by lysosomal enzymes and persist in membrane-bound residual bodies. An example of this is granules that contain lipofuscin, the yellow-brown age pigment. Lipofuscin accumulates primarily in liver cells, myocardial cells, and atrophic cells.


Hypertrophy is an increase in the size of cells and consequently in the size of the affected organ. The cells of the heart and kidneys are particularly responsive to enlargement. Hypertrophy, as an adaptive response (muscular enlargement), occurs in the striated muscle cells of both the heart and skeletal muscles. Physiologic hypertrophy in skeletal muscle occurs in response to heavy work. Muscular hypertrophy tends to diminish if the excessive workload diminishes.

The triggers for hypertrophy include two types of signals: mechanical signals, such as stretch, and trophic signals, such as growth factors and vasoactive agents. After removal of one kidney, the other kidney adapts to an increased demand for work with an increase in both the size and the number of cells. The major contribution to renal enlargement is hypertrophy.

Initial enlargement of the heart is caused by dilation of the cardiac chambers, is short-lived, and is followed by increased synthesis of cardiac muscle proteins, allowing muscle fibers to do more work. The nucleus also is hypertrophic and exhibits increased synthesis of deoxyribonucleic acid (DNA). The increase in cellular size is associated with an increased accumulation of protein in the cellular components (plasma membrane, endoplasmic reticulum, myofilaments, mitochondria) and not with an increase in the amount of cellular fluid. With time cardiac hypertrophy is characterized by extracellular matrix remodeling and increased growth of adult myocytes. The myocytes progressively increase in size and reach a limit beyond which no further hypertrophy can occur.2 Although hypertrophy can be classified as physiologic or pathologic, time may be the critical factor or determinant of the transition from physiologic to pathologic cardiac hypertrophy. Pathologic hypertrophy in the heart is secondary to hypertension or valvular dysfunction. Eventually, however, advanced hypertrophy can lead to myocardial failure (Figure 2-3), suggesting that restrictions in myocyte growth are critical determinants of ventricular dysfunction2 (see Chapter 32).

With physiologic hypertrophy, preservation of myocardial structure characterizes postnatal development, moderate endurance exercise training, pregnancy, and the early phases of increased pressure and volume loading on the adult human heart. This physiologic response is temporary, however, and aging, strenuous exercise, and sustained workload or stress lead to pathologic hypertrophy with structural and functional manifestations. A variety of intermediate signal-transduction pathways involved in myocardial growth have been reported using animal models.

Data for understanding myocyte hypertrophy have advanced; however, the reason the hypertrophied heart ultimately fails is not known. The molecular correlates that define decompensated (pathologic) hypertrophy remain obscure.2 The fetal genes present in embryonic development, α-skeletal actin and β-myosin heavy chains, have been viewed as the hallmark of pathologic hypertrophy.3

Historically it was thought that myocardial cells could not adapt to increased metabolic demands by mitotic division and production of new cells to share the work. This is now being challenged (see What’s New? Myocardial Hypertrophy, Stem Cells, Regeneration Controversy).


Hyperplasia is an increase in the number of cells resulting from an increased rate of cellular division. Hyperplasia as a response to injury occurs when the injury has been severe and prolonged.


Myocardial Hypertrophy, Stem Cells, Regeneration Controversy

The human heart has been viewed as a terminally differentiated postmitotic organ where the number of cardiomyocytes is constant from birth, and these cells persist throughout the life span. The recent discovery that cardiac stem cells exist in the heart and differentiate into various cardiac cell lineages has changed the understanding of myocardial biology profoundly. So far, four potential sources of cells may account for new cardiomyocytes after birth: (1) adult cardiomyocytes may enter the cell cycle and divide, (2) bone marrow–derived cardiac stem cells or progenitor cells that have the ability to mature into cardiomyocytes may populate the heart after injury, (3) cells from the embryonic epicardium may be present, and (4) niches of cardiac or cardiac progenitor cells (CPCs) may give rise to cardiomyocytes.

From birth to adulthood and aging, the increase in myocardial mass was assumed to be regulated by a parallel increase in volume of cardiomyocytes and the changes in cell size were equal to the changes in heart weight. In the absence of cardiac disease, the number of myocytes was thought to remain constant throughout life. Hypertrophy was promoted as the exclusive mechanism used by the heart to increase its muscle mass. Myocytes increased their volume by turnover of their cytoplasmic proteins and mitochondrial organelles. Altogether, cardiomyocytes were regarded to live and function for nearly 100 years or longer. The assumption, although unstated, was that cardiomyocytes were basically immortal and died only by pathologic processes during one’s life span. Myocytes, however, are formed postnatally and myocyte number decreases with aging. For example, investigators analyzed 74 normal human hearts of individuals 19 to 104 years of age and reported myocyte turnover in the female heart occurs at a rate of 10%, 14%, and 40% per year at 20, 60, and 100 years of age, respectively. The values were respectively 7%, 12%, and 32% per year in male hearts, demonstrating that myocyte growth involves a large and increasing number of cells with aging. However, the extent of myocyte turnover reported by different investigators varies substantially.

Ventricular dilation and wall thinning are the main structural aspects of heart failure. Understanding these structural aspects according to processes that modulate plasticity or regeneration and myocyte death will better define the cellular mechanisms of the failing heart. Cardiac stem cells or progenitor cells regulate myocyte turnover and this new novel information imposes a reconsideration of the mechanisms involved in myocardial aging and progression of myocardial hypertrophy to heart failure.

Data from Anversa P, Kajstura J, Leri A: Chapter 11: Cardiovascular regeneration and tissue engineering. In Bonow RO et al, editors: Braunwald’s heart disease: a textbook of cardiovascular medicine, ed 9, St Louis, 2012, Elsevier Saunders; Leri A, Kajstura J, Amversa P: Circ Res 109:941–961, 2011; Kajstura J et al: Circ Res 107:305–315, 2010; Kajstura J et al: Circ Res 107:1374–1386, 2010; Olivetti G et al: J Am Coll Cardiol 26:1068–1079, 1995.

Loss of epithelial cells and cells of the liver and kidney triggers DNA synthesis and mitotic division. Increased cell growth is a multistep process involving the production of growth factors, which stimulate the remaining cells to synthesize new cell components and, ultimately, to divide. Hyperplasia and hypertrophy often occur together, although the specific mechanism is unknown. Both hyperplasia and hypertrophy take place if the cells are capable of synthesizing DNA.

Two types of normal, or physiologic, hyperplasia are compensatory hyperplasia and hormonal hyperplasia. Compensatory hyperplasia is an adaptive mechanism that enables certain organs to regenerate. For example, removal of part of the liver leads to hyperplasia of the remaining liver cells (hepatocytes) to compensate for the loss. Even with removal of 70% of the liver, regeneration is complete in about 2 weeks. The remarkable regenerating capacity of the liver was even noted by the ancient Greeks. A protein, hepatocyte growth factor (HGF), is a mediator in vitro of liver regeneration. In addition, other in vitro growth factors and cytokines (cell-signaling proteins) that increase hepatic cell regeneration include transforming growth factor-alpha (TGF-α), epidermal growth factor (EGF), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α).

Not all types of mature cells have the same capacity for compensatory hyperplastic growth. Nondividing tissues contain cells that can no longer (i.e., postnatally) go through the cell cycle and undergo mitotic division. These cells include neurons and skeletal and cardiac muscle cells. Destruction of neurons in the central nervous system is usually replaced by proliferation of the glial cells, the supportive structures. Recent data, however, have demonstrated neuron development from stem cells in adult brains.4 Mature skeletal muscle cells do not divide but have been shown to have regenerative capacity from differentiation of satellite cells that are part of the endomysial sheaths. Additionally, large injury to cardiac muscle cells is followed by scar formation. However, laboratory experiments show cardiac muscle cells may have limited regenerative capacity.

Significant compensatory hyperplasia occurs in epidermal and intestinal epithelia, hepatocytes, bone marrow cells, and fibroblasts, and some hyperplasia is noted in bone, cartilage, and smooth muscle cells. An example of compensatory hyperplasia is a callus, or thickening, of the skin as a result of hyperplasia of epidermal cells in response to a mechanical stimulus. Another example is the response to wound healing as part of the inflammation process (see Chapter 7).

Hormonal hyperplasia occurs chiefly in estrogen-dependent organs, such as the uterus and breast. After ovulation, for example, estrogen stimulates the endometrium to grow and thicken for reception of the fertilized ovum. If pregnancy occurs, hormonal hyperplasia, as well as hypertrophy, enables the uterus to enlarge. (Hormone function is described in Chapters 21 and 22.)

Pathologic hyperplasia is the abnormal proliferation of normal cells and can occur as a response to excessive hormonal stimulation or the effects of growth factors on target cells (Figure 2-4). Hyperplastic cells are identified by pronounced enlargement of the nucleus, clumping of chromatin, and the presence of one or more enlarged nucleoli. The most common example is pathologic hyperplasia of the endometrium, which is caused by an imbalance between estrogen and progesterone secretion with oversecretion of estrogen (see Chapter 24). Pathologic endometrial hyperplasia, which causes excessive menstrual bleeding, is under the influence of regular growth-inhibition controls. If these controls fail, hyperplastic endometrial cells can undergo malignant transformation. (Malignant cell transformation is discussed in Chapter 12.)

Dysplasia: Not a True Adaptive Change

Dysplasia refers to abnormal changes in the size, shape, and organization of mature cells. Dysplasia is not considered a true adaptive process but is related to hyperplasia and is often called atypical hyperplasia. Dysplastic changes frequently are encountered in epithelial tissue of the cervix and respiratory tract, where they are strongly associated with common neoplastic growths and often are found adjacent to cancerous cells. Importantly, the term dysplasia does not indicate cancer and may not progress to cancer.

Dysplasia is often classified as mild, moderate, or severe; however, this subjective scheme has prompted recommendations to use either “low grade” or “high grade,” for example, of the female reproductive tract (i.e., Papanicolaou [Pap] test [discussed in Chapter 24]) (Figure 2-5). Data indicate that atypical hyperplasia is a strong predictor of breast cancer development.5,6 If the inciting stimulus is removed, dysplastic changes often are reversible.

FIGURE 2-5 Dysplasia of Uterine Cervix.
A, Mild dysplasia. B, Severe dysplasia. C, Carcinoma in situ (see Chapter 12). (From Damjanov I, Linder J: Anderson’s pathology, ed 10, St Louis, 1996, Mosby.)


Metaplasia is the reversible replacement of one mature cell by another, sometimes less differentiated, cell type. The best example of metaplasia is replacement of normal columnar ciliated epithelial cells of the bronchial (airway) lining by stratified squamous epithelial cells (Figure 2-6). The newly formed squamous epithelial cells do not secrete mucus or have cilia, causing loss of a vital protective mechanism.

Metaplasia is thought to develop from a reprogramming of stem cells existing in most epithelia or of undifferentiated mesenchymal (tissue from embryonic mesoderm) cells present in connective tissue. These precursor cells mature along a new pathway because of signals generated by cytokines and growth factors in the cell’s environment.

Bronchial metaplasia can be reversed if the inducing stimulus, usually cigarette smoking, is removed. With prolonged exposure to the inducing stimulus, however, cancerous transformation can occur.

Cellular Injury

Injury to cells and to extracellular matrix (ECM) leads to injury of tissues and organs ultimately determining the structural patterns of disease. Loss of function derives from cell and ECM injury and cell death. Cellular injury occurs if the cell is unable to maintain homeostasis—a normal or adaptive steady state—in the face of injurious stimuli or stress. Injured cells may recover (reversible injury) or die (irreversible injury). Injurious stimuli include chemical agents, lack of sufficient oxygen (hypoxia), free radicals, infectious agents, physical and mechanical factors, immunologic reactions, genetic factors, and nutritional imbalances. Types of cellular injury and their responses are summarized in Table 2-1 and Figure 2-7.

Cell injury and cell death often result from exposure to toxic chemicals, infections, and hypoxia. (Infections are discussed in Chapter 10.) The mechanisms causing chemical and hypoxic injury are perhaps the best understood. Both of these mechanisms can lead to disruption of selective permeability (i.e., transport mechanisms) of the plasma membrane; reduction or cessation of cellular metabolism; lack of protein synthesis; damage to lysosomal membranes with leakage of destructive enzymes into the cytoplasm; enzymatic destruction of cellular organelles; cellular death (exhibited by nuclear changes); and phagocytosis of the dead cell by cellular components of the acute inflammatory response (see Chapter 7). The extent of cellular injury depends on the type, state (including level of cell differentiation and increased susceptibility to fully differentiated cells), and adaptive processes of the cell, as well as the type, severity, and duration of the injurious stimulus. Two individuals exposed to an identical stimulus may incur varying degrees of cellular injury. Modifying factors, such as nutritional status, can profoundly influence the extent of injury. The precise “point of no return” that leads to cellular death is a biochemical puzzle, and the exact mechanisms responsible for the transition from reversible to irreversible cellular damage are being debated.

General Mechanisms of Cell Injury

Cells are complex units, and therefore the mechanisms responsible for cell injury leading to necrotic cell death are numerous and interrelated and depend on a delicate balance between intracellular and extracellular events. There are, however, common biochemical themes important to cell injury and cell death regardless of the injuring agent (Table 2-2). Examples of cell injury are: (1) hypoxic injury, (2) reactive oxygen species and free radical–induced injury, and (3) chemical injury.

Hypoxic Injury

Hypoxia, or lack of sufficient oxygen, is the single most common cause of cellular injury (Figure 2-8). Hypoxia can result from a reduced amount of oxygen in the air, loss of hemoglobin or hemoglobin function, decreased production of red blood cells, consequences of respiratory and cardiovascular system diseases, and poisoning of the oxidative enzymes (cytochromes) within the cells. The most common cause of hypoxia is ischemia (reduced blood supply). Hypoxia can induce inflammation and inflamed lesions can become hypoxic (Figure 2-9).

Ischemic injury is often caused by gradual narrowing of arteries (arteriosclerosis) and complete blockage by blood clots (thrombosis). Progressive hypoxia caused by gradual arterial obstruction is better tolerated than the sudden acute anoxia (total lack of oxygen) caused by a sudden obstruction, such as can occur with an embolus (a blood clot or other plug in the circulation). An acute obstruction in a coronary artery can cause myocardial cell death (infarction) within minutes if the blood supply is not restored, whereas the gradual onset of ischemia usually results in myocardial adaptation. Myocardial infarction and stroke, which are common causes of death in the United States, generally result from atherosclerosis (a type of arteriosclerosis) and consequent ischemic injury. (Vascular obstruction is discussed in Chapter 32.)

Cellular responses to hypoxic injury in heart muscle have been extensively studied. Within 1 minute after blood supply to the myocardium is interrupted, the heart becomes pale and has difficulty contracting normally. Within 3 to 5 minutes the ischemic portion of the myocardium ceases to contract. The abrupt lack of contraction is caused by a rapid decrease in mitochondrial phosphorylation, which results in insufficient adenosine triphosphate (ATP) production. Lack of ATP leads to an increase in anaerobic metabolism, which generates ATP from glycogen when there is insufficient oxygen. When glycogen stores are depleted even anaerobic metabolism ceases.

A reduction in ATP levels causes the plasma membrane’s sodium-potassium (Na+-K+) pump and sodium-calcium exchange to fail, which leads to an intracellular accumulation of sodium and calcium, resulting in cellular swelling and diffusion of potassium out of the cell. (The Na+-K+ pump is discussed in Chapter 1.) Because all cells are bathed in a fluid rich in calcium ions, cell membrane damage allows rapid movement of calcium intracellularly. The movement of water and ions into the cell causes early dilation of the endoplasmic reticulum. Dilation causes the ribosomes to detach from the rough endoplasmic reticulum, resulting in reduced protein synthesis. With continued hypoxia, the entire cell becomes markedly swollen, with increased concentrations of sodium, water, and chloride and decreased concentrations of potassium. These disruptions are reversible if oxygen is restored. If oxygen is not restored, however, there is vacuolation (formation of vacuoles or cytoplasmic small cavities) within the cytoplasm, swelling of lysosomes, and marked swelling of the mitochondria resulting from mitochondrial membrane damage. Continued hypoxic injury with accumulation of calcium subsequently activates multiple enzyme systems, including proteases, nitric oxide synthase, phospholipases, and endonuclease, resulting in cytoskeleton disruption, membrane damage, activation of inflammation, DNA and chromatin degradation, ATP depletion, and eventual cell death (see Figures 2-8 and 2-23 [p. 86]). Structurally, with plasma membrane damage, extracellular calcium readily moves into the cell and intracellular calcium stores are released.

Intracellular calcium results in the activation of enzymes that can further damage membranes, proteins, ATP, and nucleic acids. The increased permeability of the membrane causes continued loss of proteins, essential coenzymes, and ribonucleic acids. In addition, the substrates necessary to reconstitute ATP are lost. Increased intracellular calcium levels activate cell enzymes (caspases) that promote cell death by apoptosis (see Figure 2-26 [p. 89]). Continued ischemia causes irreversible injury that is associated structurally with severe swelling of the mitochondria, severe damage to plasma membranes, and swelling of lysosomes.

Acid hydrolases from leaking lysosomes are activated in the reduced pH of the injured cell and they digest cytoplasmic and nuclear components. Leakage of intracellular enzymes into the peripheral circulation provides a diagnostic tool for detecting tissue-specific cellular injury and death using blood samples; for example, the contractile protein troponin from cardiac muscle is found after myocardial injury and liver transaminases are found after hepatic injury.

Restoration of oxygen, however, can cause additional injury called reperfusion (reoxygenation) injury. Reperfusion injury results from the generation of highly reactive oxygen intermediates (oxidative stress), including hydroxyl radical (OH•), superoxide O·2image, and hydrogen peroxide (H2O2) (see p. 59). These radicals can all cause further membrane damage and mitochondrial calcium overload. The white blood cells (neutrophils) are especially affected with reperfusion injury, including neutrophil adhesion to the endothelium.

Reperfusion is a serious complication and an important mechanism of injury in instances of tissue transplantation and in myocardial, hepatic, intestinal, cerebral, renal, and other ischemic syndromes, including stroke.7 Xanthine dehydrogenase, an enzyme that normally uses oxidized nicotinamide adenine dinucleotide (NAD+) as an electron acceptor, is converted during reperfusion with oxygen to xanthine oxidase. During the ischemic period, excessive ATP consumption leads to the accumulation of the purine catabolites hypoxanthine and


Cardioprotection for Ischemia-Reperfusion Injury

Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide. Despite optimal therapy and an amazing amount of research, individuals with CHD still suffer significant morbidity and mortality. Therefore, to improve individual outcomes novel treatment strategies for protecting the heart against the detrimental effects of acute ischemia-reperfusion injury (IRI), the major pathologic consequence of CHD, are required. Cardioprotection can occur by signaling pathways initiated before or at the beginning of sustained ischemia, called preconditioning (PC), and/or cardioprotection at the very start of reperfusion, called postconditioning (see figure below). Perconditioning is a term sometimes used for the period of ischemia.

Murray and colleagues first described ischemic preconditioning (IPC) in which the application of short cycles of nonlethal ischemia and reperfusion to the canine heart reduced subsequent myocardial infarct size (IS). The problem with this strategy is the requirement for the intervention to be applied before the ischemic event, which in the case of an acute myocardial infarction (MI) is impossible to predict. However, the introduction of ischemic postconditioning in 2003, whereby the process of myocardial reperfusion is interrupted by several short-lived episodes of ischemia, overcomes this problem and can be applied at the onset of myocardial reperfusion in individuals presenting with an acute MI. Yet, both IPC and ischemic postconditioning require an intervention to be applied to the heart directly that is not feasible in all clinical settings. Therefore, remote ischemic conditioning (RIC) may provide a noninvasive endogenous therapeutic strategy (for example, with a blood pressure cuff) for protecting the heart against acute IRI. Remote ischemic conditioning is the cardioprotective effect elicited from applying one or more cycles of nonlethal ischemia reperfusion to an organ or tissue remote from the heart. Furthermore, experimental studies found that it was possible to protect non-cardiac organs and tissues from acute IRI. Thus, RIC represents a form of systemic protection against acute IRI. Recently, it was discovered that the RIC stimulus could be noninvasively induced using a standard blood pressure cuff placed on the upper arm or leg. Importantly, the timing of the RIC stimulus can accommodate most clinical settings of acute IRI (see figure below).


Data from Kharbanda RK et al: Circulation 106:2881–2883, 2002; Lim SY, Hausenloy DJ: Front Physiol 3:27, 2012.

xanthine, which upon subsequent reperfusion and influx of oxygen are metabolized by xanthine oxidase to make massive amounts of superoxide and hydrogen peroxide. These radicals can all cause membrane damage and mitochondrial calcium overload.3 Cardiac ischemia and reperfusion injury cause excessive reactive oxygen species (ROS) and calcium overload of the mitochondria. These changes presumably lead to the opening of a large conductance pore on the mitochondrial membrane called the mitochondrial permeability transition pore (MPTP) with massive escape of ATP and solutes leading to cell death activation (apoptosis).8 Cardioprotection from ischemia/reperfusion injury is an important focus of much research (see What’s New? Cardioprotection for Ischemia-Reperfusion Injury). Other potential and current treatments include use of antioxidants, blockage of inflammatory mediators, and inhibition of apoptotic pathways.

Free Radicals and Reactive Oxygen Species—Oxidative Stress

An important mechanism of membrane damage is injury induced by free radicals, especially by excess ROS called oxidative stress (Figure 2-10). Oxidative stress occurs when excess ROS overwhelms endogenous antioxidant systems (Box 2-1). A free radical is an electrically uncharged atom or group of atoms having an unpaired electron. Having one unpaired electron makes the molecule unstable; thus to stabilize, it gives up an electron to another molecule or steals one. Therefore, it is capable of injurious chemical bond formation with proteins, lipids, and carbohydrates—key molecules in membranes and nucleic acids. Free radicals are difficult to control and initiate chain reactions. Emerging data indicate that ROS play major roles in the initiation and progression of cardiovascular alterations associated with hypertension, hyperlipidemia, diabetes mellitus, ischemic heart disease, chronic heart failure, and sleep apnea.9,10 ROS generation is thought to lead to vascular endothelial injury and consequently atherosclerosis. Up-regulation of adhesion molecule production in the endothelium can be accomplished by ROS, which diminishes nitric oxide (NO) synthase activity and promotes NO breakdown. This disturbance of the vascular environment presumably causes a reduction of endothelial-dependent vasodilation.11 Such reduction in endothelium-dependent vasodilation has been demonstrated through intra-arterial infusion of vasoactive agents. Specific mechanisms by which vascular endothelial dysfunction may lead to adverse cardiovascular events include vasoconstriction, vascular smooth muscle proliferation, hypercoagulability, and thrombosis.12

ROS produced by migrating inflammatory cells (e.g., neutrophils), as well as vascular cells (endothelial cells, vascular smooth muscle cells, and adventitial fibroblasts), have distinct effects on each cell type.13 These cell effects are shown in Figure 2-11. When inflammatory responses also are activated, there is consequent activation of endothelial cells, leukocytes, and platelets. These activated cells express adhesion molecules and proinflammatory cytokines that may further exacerbate inflammatory responses and cause endothelial cell injury and dysfunction, promoting the development of cardiovascular morbidities.14

Free radicals may be initiated within cells by (1) the absorption of extreme energy sources (e.g., ultraviolet light, x-rays); (2) the occurrence of endogenous reactions, such as redox reactions in which oxygen is reduced to water, as evident in systems involved in electron and oxygen transport (all biologic membranes contain redox systems important for cellular defense, for example, inflammation, iron uptake, growth and proliferation, and signal transduction) (Figure 2-12); or (3) the enzymatic metabolism of exogenous chemicals or drugs (e.g., chloromethyl [CCl3·image], a product of carbon tetrachloride [CCl4]). Table 2-3 describes the most significant free radicals.



Reactive oxygen species (ROS)
Superoxide O·2image
O2→ oxidase O·2image
Generated either (1) directly during autooxidation in mitochondria, or (2) enzymatically by enzymes in the cytoplasm, such as xanthine oxidase or cytochrome P-450; once produced, it can be inactivated spontaneously or more rapidly by the enzyme superoxide dismutase (SOD): O·2image + O·2image + 2H+ → SOD H2O2 + O·2image O·2image, a signaling molecule in growing or differentiating tissue, including hypertrophy, can alter cellular responses to growth factors and vasoconstrictor hormones; increasing levels of O·2image may lead to apoptosis (see Figure 2-11)
Hydrogen peroxide (H2O2)
O·2image + O·2image + 2H → SOD H2O2 + O2
Oxidases present in peroxisomes
O2 peroxisome O·2image → SOD H2O2
Generated by SOD or directly by oxidases in intracellular peroxisomes; SOD is considered an antioxidant because it converts superoxide to H2O2·image, catalase (another antioxidant) can then decompose H2O2 to O2 + H2O; H2O2 can serve as a cellular signaling molecule
Hydroxyl radicals (OH•)
H2O → H• + OH•
Fe++ + H2O2 → Fe+++ + OH• + OH
H2O2 + O·2image → OH• + OH + O2
Generated by the hydrolysis of water caused by ionizing radiation or by interaction with metals—especially iron (Fe) and copper (Cu); iron is important in toxic oxygen injury because it is required for maximal oxidative cell damage; OH• is highly reactive and can modify cellular macromolecules and cause toxicity
Nitric oxide (NO)
NO• + O·2image → ONOO + H+
↑ ↓
OH• + NO2 ONOOH → NO3image
NO by itself is an important mediator that can act as a free radical; it can be converted to another radical—peroxynitrite anion (ONOO−), as well as NO2• and NO3image; NO is formed in neuronal cells, where it modulates neurotransmission; in endothelial cells as a modulator of vessel relaxation; and in neutrophils and macrophages as a factor in vessel relaxation and inactivation of pathogens


Data from Kumar V et al: Robbins & Cotran pathologic basis of disease, ed 8, Philadelphia, 2010, Saunders; Buetler TM, Krauskopf A, Ruegg UT: News Physiol Sci 19:120–123, 2004.

FIGURE 2-12 Generation of Reactive Oxygen Species (ROS) and Antioxidant Mechanisms in Biologic Systems.
Mitochondria have four sites of entry for electrons coming into the electron-transport system: one for reduced nicotinamide adenine dinucleotide (NADH) and three for the reduced form of flavin adenine dinucleotide (FADH2). These pathways meet at the small, lipophilic molecule ubiquinone (coenzyme Q), at the beginning of the common electron-transport pathway. Ubiquinone transfers electrons in the inner membrane, ultimately enabling their interaction with O2 and H2 to yield H2O. In so doing, the transport allows free energy change and the synthesis of 1 mol of adenosine triphosphate (ATP). With the transport of electrons, free radicals are generated within the mitochondria. ROS (H2O2, OH•, and O·2image and nitric oxide [NO]) act as physiologic modulators of some mitochondrial functions but also may cause cell damage. O2 is converted to superoxide (O·2image) by oxidative enzymes in the mitochondria, endoplasmic reticulum (ER), plasma membrane, peroxisomes, and cytosol. O2 is converted to H2O2 by superoxide dismutase (SOD) and further to OH• by the Cu++/Fe++ Fenton reaction. Superoxide catalyzes the reduction of Fe++ to Fe+++, thus increasing OH• formation by the Fenton reaction. H2O2 is also derived from oxidases in peroxisomes. The NO• (radical) is produced by the oxidation of one of the terminal guanido-nitrogen atoms of l-arginine. Depending on the microenvironment, NO can be converted to other reactive nitrogen species including the highly reactive peroxynitrate (ONOO). Both OH• and ONOO are very reactive and can modify cellular macromolecules and cause toxicity. The less reactive molecules O·2image and H2O2 can serve as cellular signaling molecules. The major antioxidant enzymes include SOD, catalase, and glutathione peroxidase. (Data from Dröge W: Physiol Rev 82:47–95, 2002; Buetler TM, Krauskopf A, Ruegg UT: News Physiol Sci 19:120–123, 2004.)

Although wide-ranging effects can occur from these reactive species, three are particularly important in regard to cell injury: (1) peroxidation of lipids; (2) alterations of proteins causing fragmentation of polypeptide chains; and (3) alterations of DNA, including breakage of single strands. Lipid peroxidation is the destruction of unsaturated fatty acids. Fatty acids of lipids in membranes possess double bonds between some of the carbon atoms. Such bonds are vulnerable to attack by oxygen-derived free radicals, especially OH·. The lipid-radical interactions themselves yield peroxides. The peroxides instigate a chain reaction resulting in membrane, organelle, and cellular destruction. Because of the increased understanding of free radicals, a growing number of diseases and disorders have been linked either directly or indirectly to these reactive species (Box 2-2).

Sep 9, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Altered Cellular and Tissue Biology

Full access? Get Clinical Tree

Get Clinical Tree app for offline access